MYGN:NASDAQ
Myriad Genetics Inc
US$4,28
0,00%
(0,00) 1D
US$4,30
arrow_upward
+0,47% (+0,020)bedtimeAfter hours
Closed: 7 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
US$4,25
High
US$4,32
Low
US$4,12
Mkt. cap
409,38 ລ້ານ
Avg. vol.
2,01 ລ້ານ
Volume
2,00
52-wk high
US$8,59
52-wk low
US$2,74
EPS
US$-1,20
Beta
1,64
Shares outstanding
95,65 ລ້ານ
No. of employees
3 ພັນ
Open
US$4,25
High
US$4,32
Low
US$4,12
Mkt. cap
409,38 ລ້ານ
Avg. vol.
2,01 ລ້ານ
Volume
2,00
52-wk high
US$8,59
52-wk low
US$2,74
EPS
US$-1,20
Beta
1,64
Shares outstanding
95,65 ລ້ານ
No. of employees
3 ພັນ
News stories
From web sources and news partners
Simply Wall Street
·
15 ຊົ່ວໂມງກ່ອນ
Why Myriad Genetics Bears Were Right Before The Drop
AD HOC NEWS
·
2 ມື້ກ່ອນ
Craig-Hallum raises target for Myriad Genetics stock from USD 4.00 to USD 8.00
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2,7 ພັນ
Founded1991
Headquartersເຊົາ ເລກ ຊິຕີ, ຢູທາ, ສະຫະລັດ
SectorBiotechnology
Websitemyriad.com